Home Business Page 14

Business

First cross-company deal for Cancer Research UK

New investment fund for early stage opportunities

Agreements to exploit gene editing techniques

New nanotechnology centre in Brasil

Acquisition in the hematologic and inflammatory area

Transfer of the Hyafil Centre completed

New manufacturing plant for Dengue vaccine

Drug discovery collaboration for Evotec’s iPSC platform

GE Healthcare enters orphaned IP market

EU’s Annual Growth Survey for the European Semester 2017

1...131415...29Page 14 of 29
© © 2025 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151